Seer makes the Proteograph Product Suite, a set of tools for deep, unbiased protein measurement used by life science researchers. SEER reports earnings on Tue, Nov 10, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| May 4 | Canaccord Genuity | Initiated | Buy |
Seasonality
How SEER has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.
Whale Options Flow
90DNo whale options trades in SEER in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SEER is in one of them and how their past SEER trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered SEER in an article yet. Here's the latest on the wider market.
About Seer
Seer is a life sciences company based in Redwood City, California, that makes tools for studying proteins. Its main offering, the Proteograph Product Suite, combines consumable assays, an automation instrument and data analysis software to measure proteins in samples such as blood plasma. Researchers use it to examine protein variants and modifications at the peptide level, which can add context to genetic data. Its customers include academic institutions, biopharmaceutical companies, biobanks and clinical research organizations.
- Headquarters
- Redwood City, CA